Anders Sigvard Bjartell
Fundador en Glactone Pharma AB .
Perfil
Anders Sigvard Bjartell is the founder of Glactone Pharma AB, which was founded in 2012.
He is currently a Professor at the University of Lund and the Chief Urology Officer & Professor at Skane University Hospital.
He previously worked as a Director at LIDDS AB from 2015 to 2022.
Dr. Bjartell obtained a doctorate degree from the University of Lund.
Cargos activos de Anders Sigvard Bjartell
Empresas | Cargo | Inicio |
---|---|---|
Glactone Pharma AB
Glactone Pharma AB Pharmaceuticals: MajorHealth Technology Glactone Pharma AB engages in the development of pipeline of novel signal transducer and activator of transcription 3 inhibitors. Its pipeline is used for immuno-oncology and for the treatment of drug resistant cancers, including castration resistant prostate cancer. The company was founded by Anders Sigvard Bjartell, Rebecka Hellsten, Martin Johansson, Eduardo Munoz, and Olov Arvid Sterner in 2012 and is headquartered in Helsingborg, Sweden. | Fundador | 01/01/2012 |
Skane University Hospital
Skane University Hospital Hospital/Nursing ManagementHealth Services Skane University Hospital operates a search service called Hitta Vård, which provides contact information for public and private healthcare providers in the Skåne region of Sweden. The private company is based in Malmö, Sweden. The service is financed by Region Skåne. | Corporate Officer/Principal | - |
University of Lund | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Anders Sigvard Bjartell.
Empresas | Cargo | Fin |
---|---|---|
LIDDS AB | Director/Miembro de la Junta | 02/05/2022 |
Formación de Anders Sigvard Bjartell.
University of Lund | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
LIDDS AB | Health Technology |
Empresas privadas | 2 |
---|---|
Glactone Pharma AB
Glactone Pharma AB Pharmaceuticals: MajorHealth Technology Glactone Pharma AB engages in the development of pipeline of novel signal transducer and activator of transcription 3 inhibitors. Its pipeline is used for immuno-oncology and for the treatment of drug resistant cancers, including castration resistant prostate cancer. The company was founded by Anders Sigvard Bjartell, Rebecka Hellsten, Martin Johansson, Eduardo Munoz, and Olov Arvid Sterner in 2012 and is headquartered in Helsingborg, Sweden. | Health Technology |
Skane University Hospital
Skane University Hospital Hospital/Nursing ManagementHealth Services Skane University Hospital operates a search service called Hitta Vård, which provides contact information for public and private healthcare providers in the Skåne region of Sweden. The private company is based in Malmö, Sweden. The service is financed by Region Skåne. | Health Services |
- Bolsa de valores
- Insiders
- Anders Sigvard Bjartell